CD8A and breast carcinoma: Indeed, previous studies have shown that treatment strategies invoked by our therapeutic approach such as blocking angiogenesis48, delivery of IL-12 (ref. 49) or stimulation of CD8+ T cells50 effectively reduces mammary cancers in this mouse model of breast cancer.